activation of PI 3-kinase and AKT, demonstrating that Syk is upstream of PI 3-kinase and AKT. However, constitutively active PI 3-kinase reversed this loss of AKT function caused by kinase-deficient Syk or piceatannol. Thus, Syk appears to regulate PI 3-kinase which controls AKT activity during IL2-stimulation. More importantly, we observed Rac1 activation by IL2 and found that it mediated PI 3-kinase activation of AKT. This conclusion came from experiments where dominant-negative Rac1 significantly decreased IL2-induced AKT activation while constitutively-active Rac1 re-elevated AKT activity in not only Syk-but also PI 3-kinase-impaired NK cells. These results constitute the first report of a Syk PI3K Rac1 AKT signal cascade controlled by IL2 that mediates NK cell survival.
For personal use only. on July 16, 2017 . by guest www.bloodjournal.org From 4 IL2 plays a critical role in the regulation of immune responses. It not only functions as a growth factor for NK and T cells, but also serves to promote cell survival, thus affecting the amplification of an immune response against an antigen. The IL2 receptor (IL2R) comprises a heterotrimeric complex consisting of a high affinity cytokine-binding subunit, IL2R , which associates with IL2R , and the common IL2R that is shared by other cytokine receptors, including IL-4, IL-7, IL-9 and IL-15 1 . The IL2-IL2R
interaction triggers a multitude of signaling molecules, beginning with protein tyrosine kinases 1 . The Src family kinases, Lck, Fyn and Lyn, and the Janus kinases (Jaks) closely associate with the IL2R [2] [3] [4] [5] [6] . The Jaks have been well-documented for initiating signaling of IL2. The current concept is that IL2-activated JAKs recruit critical SH2-containing signaling mediators leading to several cascades including the STATs, Ras/Raf/MEK/MAPK, and PI 3-kinase [7] [8] [9] [10] . These events then regulate the function of key transcription factors and regulators implicated in cell proliferation and differentiation 1, 11, 12 .
Despite the insight into the IL2 signaling pathways that trigger activation, those that promote cell survival in lymphocytes have not been completely elucidated. The PI 3-kinase/AKT pathway promoting survival has been implicated in IL2-activated T cells and BAF/3 cells 13, 14 . However, there is no direct binding site for PI 3-kinase in the IL2R, yet PI 3-kinase is readily activated by IL2 15 . Thus, the activation of PI 3-kinase must rely on other upstream effector(s) that associate with the IL2R. In searching for molecules that would fit this function, we narrowed in on Syk that has long been known to directly bind IL2R 16, 17 . Although much effort on Syk has been in B cells, monocytes, and mast cells, primarily delineating its key role in activating the PLC and Ras/MAPK pathways [18] [19] [20] , For personal use only. on July 16, 2017 . by guest www.bloodjournal.org From 5 some reports did suggest that Syk was involved in PI 3-kinase activation, such as the case in oxidative stress-and insulin-induced cell survival 21, 22 , and IIb 3 integrin signaling in platelet/megakaryocyte cells 23 . To critically address the issue if a specific Syk-directed pathway essentially dictates IL2 survival signaling, we utilized an IL2-dependent NK cell line and freshly isolated human large granule lymphocytes (LGLs), and examined whether Syk links IL2 to cell survival. We also attempted to identify what the downstream signal components might be. Here we demonstrated that Syk, together with PI 3-kinase, are both required for IL2-mediated NK survival and made the important discovery that Syk is one major upstream effector for PI 3-kinase/AKT in IL2 signaling.
Another important finding is the critical role of Rac1 in mediating PI 3-kinase activation of AKT.
For personal use only. To determine whether these cells underwent apoptosis, we examined their morphological changes. Two typical features of apoptosis, the condensation of nuclei and the formation of nuclear bodies, were assessed. In medium and DMSO controls only 2-4% of cells appeared to be apoptotic ( Fig. 1 B) . In contrast, a robust increase of nuclei condensation and nuclear bodies was observed after piceatannol or LY294002 treatment,
For personal use only. on July 16, 2017. by guest www.bloodjournal.org From amounting to 43% and 65%, or 38% and 57%, at 24 h and 48 h intervals (Fig. 1B) . In addition, analysis of nuclear DNA also revealed that piceatannol-and LY294002-treatment induced significant internucleosomal DNA fragmentation, another indicator of apoptosis (data not shown). These data suggest that both Syk and PI 3-kinase are required for sustaining NK viability. ). To check that AKT function, and not simply AKT phosphorylation, was affected, the same lysates were immunoprecipitated with anti-panAKT and analyzed for kinase activity using histone 2B (H 2 B) as a substrate. The results verified that AKT kinase function was also lost by piceatannol, LY294002 or wortmannin treatment in IL2-stimulated NK92 cells (Fig. 2C) . These results strongly support our proposal that Syk regulates AKT in IL2 signaling. (Fig. 2D) . Correspondingly, in vitro kinase assays showed similar impairment of IL2-stimulated AKT kinase by SykT and p85(DN) (Fig. 2D ).
Inactivation of
Syk control of IL2-stimulated PI 3-kinase activation. Thus far, our data clearly revealed that both Syk and PI 3-kinase are the critical modulators located upstream of AKT in IL2 survival signaling, but gave no clue to whether they operated within the same pathway to control AKT. Based on information from other systems where Syk regulates PI 3-kinase, we explored the impact of Syk on PI 3-kinase in IL2 signaling. NK92 cells were evaluated for PI 3-kinase-mediated inositol kinase activity by in vitro kinase assay with phosphatidylinositol (3,4) diphosphate (PI(3,4)P 2 ) as the substrate and thin-layer chromatography. Within 5 min of IL2 stimulation, PI 3-kinase immunoprecipitated by anti-p85 from NK92 cells displayed high capacity to produce PI(3,4,5)P 3 (Fig. 3) .
Piceatannol pretreatment substantially reduced this capacity; so did the expression of SykT. In contrast, expression of CD56, as a control, did not interfere with IL2-stimulated encoding Myc-p110* or CD56 prior to IL2 engagement. Virally transduced Myc-p110* was readily expressed in the cells (Fig. 4A, top panel) . IL2 elicited AKT phosphorylation in medium and DMSO+CD56 control groups. As noted before, piceatannol impaired IL2-induced AKT activation. However, this impairment was markedly reversed by the expression of Myc-p110*, whereas Myc-p110* also elevated the basal level of AKT phosphorylation (Fig. 4A, middle panel) . Equal loading of AKT was confirmed by western blotting (Fig. 4A, bottom panel) .
Analyses of AKT kinase activity, with anti-AKT immunoprecipitates using H 2 B as a substrate, demonstrated a similar pattern. IL2 sharply induced AKT function in all control groups, i.e., medium, DMSO and CD56 (Fig. 4B) . SykT effectively blocked AKT kinase function, as expected. Piceatannol + CD56-treated cells showed similarly reduced AKT activation; however, piceatannol + Myc-p110*-treated cells showed high AKT kinase 15 activity, comparable to those of the control groups (Fig. 4B) , indicating that Myc-p110* overcomes the inhibition by piceatannol. These results re-confirm that both PI 3-kinase and AKT are downstream of Syk in IL2 signaling.
Regulation of IL2-induced AKT activation by Rac1. Rac1 has been coupled to mediating PI 3-kinase signaling in various functions, including cell mobility, actin rearrangement, membrane ruffling [35] [36] [37] . However, Rac1 has also been implicated upstream of PI 3-kinase to regulate AKT activation following TCR engagement 38 . We therefore determined if Rac1 was involved in AKT activation in IL2 signaling. While DMSO, DMSO plus CD56, and DMSO plus V12Rac1 controls all exhibited a high level of AKT activity, piceatannol-, and LY294002 abrogated this activation (Fig. 5C ).
However, V12Rac1 remarkably counteracted the inhibitory effect of piceatannol to restore AKT function (Fig. 5C) . Moreover, V12Rac1 also restored AKT activation lost in LY294002-treated NK cells, demonstrating that Rac1 was downstream of both Syk and PI 3-kinase (Fig. 5C ). Taken together, these data clearly suggest that a specific signaling cascade is triggered by IL2 that involves sequential activation of Syk, PI 3-kinase, Rac1 that leads to AKT activation.
Validation of this Syk-dependent IL2 signaling in human NK cells. To confirm
that the same pathway is physiologically relevant and not isolated to the NK92 cell line, we extended our observations to fresh LGL cells from normal donors cultured in IL2-containing medium. Again, we found a marked induction of apoptosis in piceatannol-or
LY294002-treated
LGLs, demonstrated by Annexin V labeling (Fig. 6A) . Internuclear DNA fragmentation showed the same results (data not shown).
Inspection of AKT phosphorylation and kinase function correspondingly showed similar results as those obtained from NK92 cells. Piceatannol notably suppressed IL2-induced AKT phosphorylation and kinase function in LGLs, which were significantly reelevated by expression of V12Rac1 (Fig. 6B, C 52 . In T cells p36/38 linker protein also provides a bridge to the recruitment/activation of PI 3-kinase via its phosphorylation by Syk or a Syk-regulated kinase following TCR-triggering 53 . It remains to be seen which pathway mediates Syk activation of PI 3-kinase in IL2 signaling, but it seems more likely that Gab2 is responsible via Shc, particularly based on the report that IL2 induces Gab2 activation 48, 49 AKT is conventionally considered to be activated in a PI 3-kinase-dependent manner [54] [55] [56] . Our findings indicate that AKT activation by IL2 is also Syk-dependent.
This observation is supported in other systems. BCR-induced AKT activation requires
Syk, while Lyn acts as an endogenous antagonist for this activation, implying a mechanism for the delicate adjustment on BCR-triggered AKT 57 . Syk is also required for the activation of the PI 3-kinase/AKT survival pathway induced by oxidative stress in B cells 21 . Additionally, Syk regulates AKT activation in platelet/megakaryocyte-specific IIb 3 integrin signaling in fibrinogen-adherent cells 23 .
Although AKT dependency on Syk is becoming known, its reliance on Rac1 is a novel finding. This conclusion came from experiments here in this study whereby 
effectors, depending on the kinases that are ultimately regulated. At least, in NK cells, we were able to dissect out 2 distinct pathways utilizing Rac1, depending on the receptor. NK receptor engagement by tumor cells triggered Rac1-dependent ERK that drives lytic function 65 , while IL2R engagement elicited Rac1-dependent AKT activation that controls survival. Of note, is that both NK receptor engagement and IL2R engagement triggered Syk activation leading initially to activation of PI 3-kinase, followed by Rac1. However, substrates downstream of Rac1 differ depending on either lytic function or cell survival.
This is the first report documenting a novel linkage between Syk and Rac1 in control of IL2-mediated NK survival. These data have provided functional and biochemical evidence pertaining to the sequential and specific interaction of Syk, PI 3-kinase, Rac1
and AKT in NK cells to prevent apoptosis, while the cytotoxic function of human NK cells also requires the sequential interaction of these molecules 64, 65 .
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